-+ 0.00%
-+ 0.00%
-+ 0.00%

Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update

Barchart·12/19/2025 06:30:00
Listen to the news

Avicanna’s evidence-based pathway for cannabinoid-based medicine aligns with the executive order.

Avicanna’s 2025 advances across R&D, clinical development, and medical affairs.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.